TOL101
TOL101
TOL101 (pronounced: /tɒl ˈwʌn oʊ ˈwʌn/) is a medical term referring to a specific type of immunosuppressive drug used in the field of transplantation medicine. The term is derived from the abbreviation of the drug's full name, "Tolerogenixx 101".
Etymology
The term "TOL101" is a combination of the prefix "TOL", an abbreviation for "Tolerogenixx", and the suffix "101", a common numerical designation in scientific nomenclature. "Tolerogenixx" is a pharmaceutical company known for its research and development of innovative immunosuppressive drugs.
Usage
In medical literature, TOL101 is often used to refer to the drug developed by Tolerogenixx that is used to prevent organ rejection in patients who have undergone organ transplantation. It is a type of monoclonal antibody that targets and inhibits specific immune cells that are responsible for organ rejection.
Related Terms
- Immunosuppressive drug: A type of drug that reduces the body's immune response, often used to prevent the body from rejecting a transplanted organ.
- Transplantation medicine: A medical specialty that involves the transplantation of organs, tissues, or cells from one individual to another.
- Organ rejection: A process in which the immune system attacks a transplanted organ or tissue, perceiving it as a foreign body.
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
External links
- Medical encyclopedia article on TOL101
- Wikipedia's article - TOL101
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski